|
Listed on Euronext Paris since April 2002 and recently promoted to the Deferred Settlement Service. the ORPEA group is a leading player in the Long-Term Care and Post-Acute Care sectors. As of 1st September 2007. the Group has a unique European network of healthcare facilities. with 19 738 beds (16 130 of them operational) across 213 sites. including:
- 16 368 beds in France: 12 998 operational (including 2 050 being renovated) + 3 370 under construction. spread across 180 sites.
- 3 370 beds in Europe (Spain. Belgium. Italy and Switzerland): 3 132 operational (including 328 being
renovated) + 238 under construction. spread across 33 sites.Listed on Euronext Paris Compartment A of NYSE Euronext - ISIN: FR0000184798 Yves Le Masne, Chief Operating Officer, commented: "ORPEA achieved a further acceleration in sales in the final quarter with growth of 35.7% and a sharp rise in the contribution from international activities. Full year sales for 2007 were up 31.5% to over €545m, ahead of the target of €535m. This strong performance was driven by robust organic growth of 11% coupled with a sustained level of acquisitions contributing 20.5%. ORPEA continues to harvest the fruits of its value-creating strategy combining new authorisations with selective acquisitions and its now tried and tested integration model."
Doctor Jean-Claude Marian, Chairman and Chief Executive Officer, concluded: "The ORPEA Group is fully confident in its ability to produce continued strong growth coupled with robust profitability, both in 2008 and in the following years. This confidence is based on the Group's strong position in a business sector which is not only largely protected from economic cycles but also allows an extremely good visibility, due to the rapidly growing and considerable need for long-term care provision in Europe.
On the subject, on 18 March next, the Group will give an update on its development, and the extension of its network since September 2007. It will also unveil its sales target for 2008." (CS della Società)
|
